Differential Expression of Peroxiredoxins in Prostate Cancer: Consistent Upregulation of PRDX3 and PRDX4

BACKGROUND: The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa. METHODS: Transcript expression of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Basu, Anamika, Banerjee, Hiya, Rojas, Heather, Martinez, Shannalee R., Roy, Sourav, Jia, Zhenyu, Lilly, Michael B., De León, Marino, Casiano, Carlos A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107902/
https://ncbi.nlm.nih.gov/pubmed/21031435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21292
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky